Gamal A. Soliman
- Pharmacology top 2%
- Drug-Induced Hepatotoxicity and Protection 20
- Pharmacological Effects of Natural Compounds 14
- Biochemistry top 5%
- Pharmaceutical Science top 2%
- Food Science top 5%
- Essential Oils and Antimicrobial Activity 12
-
- Natural Antidiabetic Agents Studies 13
-
- Phytochemistry and Biological Activities 10
- Ethnobotanical and Medicinal Plants Studies 8
-
- Natural product bioactivities and synthesis 8
- Plant Toxicity and Pharmacological Properties 8
- Co-authors
- Amani S. AwaadRehab F. Abdel‐RahmanDerek J. MaitlandReham M. El‐MeligySaleh I. AlqasoumiMaged S. Abdel‐KaderHanan A. OgalyMd. Khalid Anwer
- Partner nations
- EgyptSaudi ArabiaTürkiye
In The Last Decade
Gamal A. Soliman
128 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 118
- Pharmacology 263
- Biochemistry 160
- Pharmaceutical Science 144
- Complementary and alternative medicine 167
- Food Science 273
Countries citing papers authored by Gamal A. Soliman
This map shows the geographic impact of Gamal A. Soliman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamal A. Soliman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamal A. Soliman more than expected).
Fields of papers citing papers by Gamal A. Soliman
This network shows the impact of papers produced by Gamal A. Soliman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamal A. Soliman. The network helps show where Gamal A. Soliman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gamal A. Soliman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 9 | |
| 6 | 2023 | 10 | |
| 7 | 2021 | 3 | |
| 8 | 2020 | 11 | |
| 9 | 2020 | 14 | |
| 10 | 2019 | 12 | |
| 11 | 2019 | 40 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 5 | |
| 14 | 2015 | 14 | |
| 15 | Serum Micro RNA-122 as a Biomarker for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients | 2015 | 3 |
| 16 | Cytotoxic and antimicrobial activities of Emex spinosa (L.) Campd. extract. | 2014 | 8 |
| 17 | HEPATOPROTECTIVE AND HEPATOTHERAPUTIC EFFECTS OF PROPOLIS AGAINST D-GALACTOSAMINE/LIPOPOLYSACCHARIDE-INDUCED LIVER DAMAGE IN RATS | 2014 | 5 |
| 18 | EVALUATING THE ANTIFERTILITY POTENTIAL OF THE ETHANOLIC EXTRACTS OF BUPLEURUM SULPHUREUM AND CICHORIUM INTYBUS IN MALE RATS | 2013 | 11 |
| 19 | 2008 | 15 | |
| 20 | 1999 | 2 |
About Gamal A. Soliman
Gamal A. Soliman is a scholar working on Pharmacology, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism, having authored 133 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (20 papers), Pharmacological Effects of Natural Compounds (14 papers), Natural Antidiabetic Agents Studies (13 papers), Essential Oils and Antimicrobial Activity (12 papers), Phytochemistry and Biological Activities (10 papers), Ethnobotanical and Medicinal Plants Studies (8 papers), Natural product bioactivities and synthesis (8 papers) and Plant Toxicity and Pharmacological Properties (8 papers). The work is most often cited by research in Pharmacology (263 citations), Biochemistry (160 citations) and Pharmaceutical Science (144 citations). Gamal A. Soliman has collaborated with scholars based in Egypt, Saudi Arabia and Türkiye. Frequent co-authors include Amani S. Awaad, Rehab F. Abdel‐Rahman, Derek J. Maitland, Reham M. El‐Meligy, Saleh I. Alqasoumi, Maged S. Abdel‐Kader, Hanan A. Ogaly, Md. Khalid Anwer, Reham M. Abd‐Elsalam and Hasan S. Yusufoglu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.